Skip to main content
. 2022 Apr 21;9:858261. doi: 10.3389/fnut.2022.858261

FIGURE 6.

FIGURE 6

TBs-C inhibits the PI3K/AKT/mTOR pathway in NSCLC cells. The expression of major proteins in the PI3K/AKT/mTOR pathway and the AKT/p21 signal axis was detected by Western blotting in cells treated with different concentrations of TBs-C, with β-actin was used as a reference.